Status:
COMPLETED
Ivermectin Versus Albendazole for Chronic Strongyloidiasis
Lead Sponsor:
Mahidol University
Collaborating Sponsors:
Atlantic Laboratory Ltd
Conditions:
Chronic Strongyloidiasis
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conduc...
Eligibility Criteria
Inclusion
- Patients with positive strongyloides larva in the stool
Exclusion
- Pregnancy
- Lactating women
- Known allergy to any study drug
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00765024
Start Date
July 1 2008
End Date
April 1 2010
Last Update
September 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj Hospital
Bangkoknoi, Bangkok, Thailand, 10700